BG Medicine Inc. (OTCMKTS:BGMD) Short Interest Update

BG Medicine Inc. (OTCMKTS:BGMD) saw a significant growth in short interest in the month of October. As of October 15th, there was short interest totaling 500 shares, a growth of 400.0% from the September 30th total of 100 shares. Based on an average daily volume of 1,400 shares, the days-to-cover ratio is currently 0.4 days. Based on an average daily volume of 1,400 shares, the days-to-cover ratio is currently 0.4 days.

BG Medicine Stock Performance

BG Medicine has a 52-week low of $0.00 and a 52-week high of $0.00.

BG Medicine Company Profile

BG Medicine, Inc engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.